Previous studies demonstrated that quinacrine inhibits SSRP1 expression.[38, 56, 57] CBL0137, a FACT complex inhibitor that was modeled on quinacrine, is also undergoing several clinical trials for hematological malignancies and solid tumors (NCT04870944, NCT01905228, NCT02931110, and NCT03727789). The gene discussed is SSRP1; the disease is hematologic disorder.